The Cardiac Genome Clinic: implementing genome sequencing in pediatric heart disease.

Published on Feb 10, 2020in Genetics in Medicine8.904
· DOI :10.1038/S41436-020-0757-X
Miriam S. Reuter18
Estimated H-index: 18
Rajiv Chaturvedi27
Estimated H-index: 27
+ 20 AuthorsRebekah Jobling14
Estimated H-index: 14
This study investigated the diagnostic utility of nontargeted genomic testing in patients with pediatric heart disease. We analyzed genome sequencing data of 111 families with cardiac lesions for rare, disease-associated variation. In 14 families (12.6%), we identified causative variants: seven were de novo (ANKRD11, KMT2D, NR2F2, POGZ, PTPN11, PURA, SALL1) and six were inherited from parents with no or subclinical heart phenotypes (FLT4, DNAH9, MYH11, NEXMIF, NIPBL, PTPN11). Outcome of the testing was associated with the presence of extracardiac features (p = 0.02), but not a positive family history for cardiac lesions (p = 0.67). We also report novel plausible gene–disease associations for tetralogy of Fallot/pulmonary stenosis (CDC42BPA, FGD5), hypoplastic left or right heart (SMARCC1, TLN2, TRPM4, VASP), congenitally corrected transposition of the great arteries (UBXN10), and early-onset cardiomyopathy (TPCN1). The identified candidate genes have critical functions in heart development, such as angiogenesis, mechanotransduction, regulation of heart size, chromatin remodeling, or ciliogenesis. This data set demonstrates the diagnostic and scientific value of genome sequencing in pediatric heart disease, anticipating its role as a first-tier diagnostic test. The genetic heterogeneity will necessitate large-scale genomic initiatives for delineating novel gene–disease associations.
📖 Papers frequently viewed together
4 Citations
4 Citations
6 Citations
#1Julie De Backer (Ghent University Hospital)H-Index: 44
#2Antoine Bondue (ULB: Université libre de Bruxelles)H-Index: 14
Last. Jolien W. Roos Hesselink (EUR: Erasmus University Rotterdam)H-Index: 2
view all 12 authors...
Thanks to a better knowledge of the genetic causes of many diseases and an improvement in genetic testing techniques, genetics has gained an important role in the multidisciplinary approach to diag...
15 CitationsSource
#1Casey A. GiffordH-Index: 15
#2Sanjeev S. RanadeH-Index: 13
Last. Deepak SrivastavaH-Index: 106
view all 14 authors...
Complex genetic mechanisms are thought to underlie many human diseases, yet experimental proof of this model has been elusive. Here, we show that a human cardiac anomaly can be caused by a combination of rare, inherited heterozygous mutations. Whole-exome sequencing of a nuclear family revealed that three offspring with childhood-onset cardiomyopathy had inherited three missense single-nucleotide variants in the MKL2 , MYH7 , and NKX2-5 genes. The MYH7 and MKL2 variants were inherited from the a...
69 CitationsSource
#1Dimuthu Alankarage (VCCRI: Victor Chang Cardiac Research Institute)H-Index: 3
#2Eddie Ip (VCCRI: Victor Chang Cardiac Research Institute)H-Index: 4
Last. Sally L. Dunwoodie (VCCRI: Victor Chang Cardiac Research Institute)H-Index: 46
view all 21 authors...
Congenital heart disease (CHD) affects up to 1% of live births. However, a genetic diagnosis is not made in most cases. The purpose of this study was to assess the outcomes of genome sequencing (GS) of a heterogeneous cohort of CHD patients. Ninety-seven families with probands born with CHD requiring surgical correction were recruited for genome sequencing. At minimum, a proband–parents trio was sequenced per family. GS data were analyzed via a two-tiered method: application of a high-confidence...
20 CitationsSource
#1David P. BickH-Index: 31
#2Marilyn C. Jones (Boston Children's Hospital)H-Index: 37
Last. John W Belmont (Illumina)H-Index: 7
view all 5 authors...
Up to 350 million people worldwide suffer from a rare disease, and while the individual diseases are rare, in aggregate they represent a substantial challenge to global health systems. The majority of rare disorders are genetic in origin, with children under the age of five disproportionately affected. As these conditions are difficult to identify clinically, genetic and genomic testing have become the backbone of diagnostic testing in this population. In the last 10 years, next-generation seque...
34 CitationsSource
#1Miriam S. Reuter (The Centre for Applied Genomics)H-Index: 18
#2Rebekah JoblingH-Index: 14
Last. Anne S. BassettH-Index: 65
view all 21 authors...
To determine disease-associated single-gene variants in conotruncal defects, particularly tetralogy of Fallot (TOF). We analyzed for rare loss-of-function and deleterious variants in FLT4 (VEGFR3) and other genes in the vascular endothelial growth factor (VEGF) pathway, as part of a genome sequencing study involving 175 adults with TOF from a single site. We identified nine (5.1%) probands with novel FLT4 variants: seven loss-of-function, including an 8-kb deletion, and two predicted damaging. I...
35 CitationsSource
view all 7 authors...
7 CitationsSource
#1Slavé Petrovski (AstraZeneca)H-Index: 39
#2Vimla S. Aggarwal (CUMC: Columbia University Medical Center)H-Index: 11
Last. Ronald J. Wapner (CUMC: Columbia University Medical Center)H-Index: 100
view all 22 authors...
Summary Background Identification of chromosomal aneuploidies and copy number variants that are associated with fetal structural anomalies has substantial value. Although whole-exome sequencing (WES) has been applied to case series of a few selected prenatal cases, its value in routine clinical settings has not been prospectively assessed in a large unselected cohort of fetuses with structural anomalies. We therefore aimed to determine the incremental diagnostic yield (ie, the added value) of WE...
148 CitationsSource
#1Donna J. Page (MAHSC: Manchester Academic Health Science Centre)H-Index: 3
Last. Bernard Keavney (MAHSC: Manchester Academic Health Science Centre)H-Index: 62
view all 34 authors...
Rationale: Familial recurrence studies provide strong evidence for a genetic component to the predisposition to sporadic, nonsyndromic Tetralogy of Fallot (TOF), the most common cyanotic congenital...
51 CitationsSource
#1Keren Machol (BCM: Baylor College of Medicine)H-Index: 6
#2Justine Rousseau (UdeM: Université de Montréal)H-Index: 14
Last. Philippe M. Campeau (UdeM: Université de Montréal)H-Index: 36
view all 205 authors...
SMARCC2 (BAF170) is one of the invariable core subunits of the ATP-dependent chromatin remodeling BAF (BRG1-associated factor) complex and plays a crucial role in embryogenesis and corticogenesis. Pathogenic variants in genes encoding other components of the BAF complex have been associated with intellectual disability syndromes. Despite its significant biological role, variants in SMARCC2 have not been directly associated with human disease previously. Using whole-exome sequencing and a web-bas...
24 CitationsSource
#1Niki T. LogesH-Index: 26
#2Dinu Antony (Radboud University Nijmegen)H-Index: 12
Last. Miriam Schmidts (Radboud University Nijmegen)H-Index: 34
view all 27 authors...
Dysfunction of motile monocilia, altering the leftward flow at the embryonic node essential for determination of left-right body asymmetry, is a major cause of laterality defects. Laterality defects are also often associated with reduced mucociliary clearance caused by defective multiple motile cilia of the airway and are responsible for destructive airway disease. Outer dynein arms (ODAs) are essential for ciliary beat generation, and human respiratory cilia contain different ODA heavy chains (...
49 CitationsSource
Cited By15
#1Nejat Mahdieh (Tehran University of Medical Sciences)H-Index: 17
#2Bahareh Rabbani (IUMS: Iran University of Medical Sciences)H-Index: 12
Last. Majid Maleki (IUMS: Iran University of Medical Sciences)H-Index: 16
view all 3 authors...
Abstract null null Genetic diagnoses especially using single-gene and/or NGS tests are available for inherited cardiovascular diseases. NGS technologies have revolutionized our understanding of the molecular mechanisms of cardiovascular disorders, which provides insights on potential therapies. Cascade screening is recommended when a pathogenic variant is identified in a patient. In the genetic evaluation of a child with a congenital heart defect (CHD), it is a critical step to determine if it i...
#1Hannah E. Ison (Stanford University)H-Index: 1
#2Emily Griffin (CUMC: Columbia University Medical Center)H-Index: 2
Last. Sara Fitzgerald-Butt (IU: Indiana University)H-Index: 14
view all 14 authors...
Congenital heart disease (CHD) is an indication which spans multiple specialties across various genetic counseling practices. This practice resource aims to provide guidance on key considerations when approaching counseling for this particular indication while recognizing the rapidly changing landscape of knowledge within this domain. This resource was developed with consensus from a diverse group of certified genetic counselors utilizing literature relevant for CHD genetic counseling practice a...
#1Benjamin M. Helm (IU: Indiana University)H-Index: 7
#2Benjamin J. Landis (IU: Indiana University)H-Index: 2
Last. Stephanie M. Ware (IU: Indiana University)H-Index: 11
view all 0 authors...
The use of clinical genetics evaluations and testing for infants with congenital heart defects (CHDs) is subject to practice variation. This single-institution cross-sectional study of all inpatient infants with severe CHDs evaluated 440 patients using a cardiovascular genetics service (2014–2019). In total, 376 (85.5%) had chromosome microarray (CMA), of which 55 (14.6%) were diagnostic in syndromic (N = 35) or isolated (N = 20) presentations. Genetic diagnoses were made in all CHD classes. Dia...
#2Rajiv R. Chaturvedi (MSH: Mount Sinai Hospital, Toronto)
#9Candice K. Silversides (UHN: University Health Network)
Background - Tetralogy of Fallot (TOF), the most common cyanotic heart defect in newborns, has evidence of multiple genetic contributing factors. Identifying variants that are clinically relevant is essential to understand patient-specific disease susceptibility and outcomes, and could contribute to delineating pathomechanisms. Methods - Using a clinically-driven strategy, we re-analyzed exome sequencing data from 811 probands with TOF, to identify rare loss-of-function and other likely pathogen...
#1Lixia Yue (UConn: University of Connecticut)H-Index: 38
#2Haoxing Xu (UM: University of Michigan)H-Index: 53
The transient receptor potential (TRP) channel superfamily consists of a large group of non-selective cation channels that serve as cellular sensors for a wide spectrum of physical and environmental stimuli. The 28 mammalian TRPs, categorized into six subfamilies, including TRPC (canonical), TRPV (vanilloid), TRPM (melastatin), TRPA (ankyrin), TRPML (mucolipin) and TRPP (polycystin), are widely expressed in different cells and tissues. TRPs exhibit a variety of unique features that not only dist...
#1Martin Broberg (UH: University of Helsinki)H-Index: 8
#2Johanna Hästbacka (Boston Children's Hospital)H-Index: 1
Last. Emmi Helle (Boston Children's Hospital)H-Index: 1
view all 3 authors...
#1Ansley M. Morrish (Children's Hospital at Westmead)
#2Janine Smith (USYD: University of Sydney)H-Index: 18
Last. Gillian M. Blue (USYD: University of Sydney)H-Index: 14
view all 9 authors...
Abstract Genetic and genomic testing in pediatric CHD is becoming increasingly routine, and can have important psychosocial, clinical and reproductive implications. In this paper we highlight important challenges and considerations when providing genetics consults and testing in pediatric CHD and illustrate the role of a dedicated CHD genetics clinic. Key lessons include that a) a genetic diagnosis can have clinical utility that justifies testing early in life, b) adequate genetic counselling is...
#1Iris Cohn (U of T: University of Toronto)H-Index: 4
#2Roozbeh ManshaeiH-Index: 6
Last. Shinya Ito (U of T: University of Toronto)H-Index: 47
view all 16 authors...
Importance Pharmacogenomic (PGx) testing provides preemptive pharmacotherapeutic guidance regarding the lack of therapeutic benefit or adverse drug reactions of PGx targeted drugs. Pharmacogenomic information is of particular value among children with complex medical conditions who receive multiple medications and are at higher risk of developing adverse drug reactions. Objectives To assess the implementation outcomes of a PGx testing program comprising both a point-of-care model that examined t...
1 CitationsSource
#1Arman Zhao (Boston Children's Hospital)
#2Jie Shen (Boston Children's Hospital)
Last. Ling Sun (Boston Children's Hospital)H-Index: 5
view all 10 authors...
Background and aims Biallelic missense variants in PPA2 gene cause infantile sudden cardiac failure (SCFI; OMIM #617222) characterized by sudden cardiac failure, sudden cardiac death in infants. Here, we present an unusual survivor with one inherited plus one de novo variant in PPA2. Since next-generation sequencing (NGS) fails to resolve variant phasing, which require long-read sequencing to clarify the diagnosis. Materials and methods Whole exome and Sanger sequencing were initially performed ...
1 CitationsSource
Precision medicine aims to provide a whole new set of tools for clinicians and other healthcare providers. Armed with the latest techniques in genetic testing and next-generation sequencing, including whole genome sequencing and whole exome sequencing, physicians can now find diagnoses for rare diseases that remained elusive, ending diagnostic odysseys. Fetal exome sequencing has proved to be a useful tool for reclassifying fetal diagnoses made through traditional methods such as ultrasound and ...